BAX 326 Pediatric Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to assess BAX 326 pharmacokinetic parameters, to evaluate its hemostatic efficacy, safety, immunogenicity, and changes in health-related quality of life in pediatric patients.
Epistemonikos ID: b6851728cee3a473bb3c53e013cad52ff94e4f36
First added on: May 10, 2024